2026 BD opportunity scan for Biocad CJSC: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for Bio-Thera Solutions, Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for Bharat Biotech International Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rati

2026 BD opportunity scan for Benuvia Therapeutics, Inc.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for Beijng Immunoah Pharma Tech Co., Ltd: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach r

2026 BD opportunity scan for Beijing Tide Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach

2026 BD opportunity scan for Beijing Shuoxing Biomedical Technology Co. Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and

2026 BD opportunity scan for Beijing Northland Biotech.Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach ra

2026 BD opportunity scan for Beijing Minhai Biological Technology Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and

2026 BD opportunity scan for Beijing Luzhu Biopharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outre

2026 BD opportunity scan for Beijing Kexing Zhongwei Biotechnology Co. Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and

2026 BD opportunity scan for Beijing Jinchengtaier Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and